Jul 27, 2023 / 01:00AM GMT
Unidentified Participant
Thank you for standing by, and welcome to the PainChek investor webinar and Q&A following the company's quarterly update. Please note that the presentation being used today has just been lodged with the ASX. (Unidentified Participant Instructions) And please note that today's session is being recorded.
On behalf of PainChek today, we have the CEO and Managing Director, Philip Daffas. I'll hand it over to you, Philip. Go ahead.
Philip Daffas - PainChek Limited - CEO & MD
Thank you, [Matt], and thank you, everyone, for attending today. Real pleasure to catch up with you again at the end of this quarter and to present the quarter results of PainChek.
These results really do reaffirm the value and the rapid take-up of PainChek technology in multiple markets across, now, three continents. This is making PainChek now a new global standard in assessing pain for vulnerable people within aged care, with the home care, and with the hospital sector.
So some background on PainChek first. Our purpose is quite simple. It's
Q4 2023 PainChek Ltd Activities Report Call Transcript
Jul 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers